| Authors: |
Lenk L; Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany., Baccelli I; OSE Immunotherapeutics, Nantes, France., Laqua A; Department of Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany., Heymann J; Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany., Reimer C; Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany., Dietterle A; Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany., Winterberg D; Division of Antibody-Based Immunotherapy, Department of Medicine II, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany., Mary C; OSE Immunotherapeutics, Nantes, France., Corallo F; OSE Immunotherapeutics, Nantes, France., Taurelle J; OSE Immunotherapeutics, Nantes, France., Narbeburu E; OSE Immunotherapeutics, Nantes, France., Neyton S; OSE Immunotherapeutics, Nantes, France., Déramé M; OSE Immunotherapeutics, Nantes, France., Pengam S; OSE Immunotherapeutics, Nantes, France., Vogiatzi F; Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany., Bornhauser B; Department of Pediatric Hematology/Oncology, University Children's Hospital, Zurich, Switzerland., Bourquin JP; Department of Pediatric Hematology/Oncology, University Children's Hospital, Zurich, Switzerland., Raffel S; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany., Dovhan V; Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany., Schüler T; Institute of Molecular and Clinical Immunology, Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany., Escherich G; Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., den Boer ML; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Boer JM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Wessels W; Department of Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany., Peipp M; Division of Antibody-Based Immunotherapy, Department of Medicine II, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany., Alten J; Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany., Antić Ž; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Bergmann AK; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Schrappe M; Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany., Cario G; Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrecht University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany., Brüggemann M; Department of Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany., Poirier N; OSE Immunotherapeutics, Nantes, France., Schewe DM; Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany. |
